The contractor shall provide the FDA with the following: i. Products listed in attachment 1 (pharmaceutical pricing list), in response to government orders. At a minimum, this table will be updated…
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75F40121D00018
- Awardee
-
We Pharma, Inc. UEI EWAMVJSFNK29
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 4 $3,866,310 obligated
Award facts
- Opportunity
-
- FDA21RFQ1238675 Solicitation number
- Combined order value
- $3,866,310 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 64% used
- $6,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- Q999 Medical- Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Food and Drug Administration awarded a single-award indefinite delivery contract to We Pharma, Inc. on June 25, 2021, with a $6 million ceiling and ultimate completion date of August 5, 2026. We Pharma, Inc., doing business as WEP Clinical, is a self-certified small disadvantaged business.
The IDIQ requires We Pharma to provide pharmaceutical products listed in an annually updated pricing list in response to government orders, and to supply emergency overnight delivery services. Place of performance includes Silver Spring, Maryland and Takoma Park, Maryland, with subordinate operations in North Carolina.
The contract supports FDA research and regulatory activities, including the Generic Drug User Fee Amendments (GDUFA) regulatory science program and the Office of Pharmaceutical Quality Research (OPQR). The period of performance runs through August 5, 2026.
Recent delivery orders issued under this IDIQ include a $2 million firm fixed-price order awarded August 2, 2021, for pharmaceutical products supporting FDA operations in Silver Spring, Maryland; a $145,636.17 order dated June 15, 2022, for pharmaceutical products supporting domestic manufacturing at the Silver Spring location; a $240,000 order issued March 23, 2023, for pharmaceutical products supporting domestic manufacturing and regulatory purposes at Takoma Park, Maryland; and a $1.507 million order awarded July 28, 2025, for currently marketed drug products supporting GDUFA regulatory science research at Takoma Park, Maryland, extending through August 6, 2030.
Description
The contractor shall provide the FDA with the following: i. Products listed in attachment 1 (pharmaceutical pricing list), in response to government orders. At a minimum, this table will be updated once a year. II. Supply emergency overnight deli
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75F40121D00018?
75F40121D00018 was awarded to We Pharma, Inc. by Food and Drug Administration (Department of Health and Human Services) on June 25, 2021.
How much is contract 75F40121D00018 worth?
Orders under 75F40121D00018 have obligated $3,866,310. 75F40121D00018's own ceiling is $6,000,000.
How many orders have been placed under contract 75F40121D00018?
4 orders have been placed under 75F40121D00018, the latest on July 28, 2025.
Who can order from contract 75F40121D00018?
75F40121D00018 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75F40121D00018 competed?
The extent of competition for 75F40121D00018 was competed under sap. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV